Connection
Alok Singh to BCG Vaccine
This is a "connection" page, showing publications Alok Singh has written about BCG Vaccine.
|
|
Connection Strength |
|
 |
|
 |
|
1.312 |
|
|
|
-
Singh AK, Praharaj M, Lombardo KA, Yoshida T, Matoso A, Baras AS, Zhao L, Srikrishna G, Huang J, Prasad P, Powell JD, Kates M, McConkey D, Pardoll DM, Bishai WR, Bivalacqua TJ. Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancer. Nat Commun. 2022 02 15; 13(1):878.
Score: 0.768
-
Lombardo KA, Obradovic A, Singh AK, Liu JL, Joice G, Kates M, Bishai W, McConkey D, Chaux A, Eich ML, Rezaei MK, Netto GJ, Drake CG, Tran P, Matoso A, Bivalacqua TJ. BCG invokes superior STING-mediated innate immune response over radiotherapy in a carcinogen murine model of urothelial cancer. J Pathol. 2022 02; 256(2):223-234.
Score: 0.190
-
Singh AK, Srikrishna G, Bivalacqua TJ, Bishai WR. Recombinant BCGs for tuberculosis and bladder cancer. Vaccine. 2021 12 08; 39(50):7321-7331.
Score: 0.187
-
Dey RJ, Dey B, Singh AK, Praharaj M, Bishai W. Bacillus Calmette-Gu?rin Overexpressing an Endogenous Stimulator of Interferon Genes Agonist Provides Enhanced Protection Against Pulmonary Tuberculosis. J Infect Dis. 2020 03 16; 221(7):1048-1056.
Score: 0.168
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|